share_log

美股收盘:利好层层叠叠 纳指上演“深V起飞” 特朗普概念股独自受伤

US stock market closing: Bullish layers are stacked, Nasdaq staged a "deep V takeoff", Donald Trump concept stocks injured alone.

cls.cn ·  06:23

①Harris's campaign is going well, with photovoltaic concept stocks leading the way, and First Solar leading the S&P 500 index; ②News of production cuts stimulates a sharp rise in the lithium mining sector; ③Russia is considering restricting the export of certain strategic raw materials, leading to a collective increase in uranium producers; ④Trump's media and technology stocks fell more than 10% to a new low since landing in the US stock market.

On the evening of September 12, according to Caixin, although there was disruptive CPI data, the US stock market regained strength after falling for an hour and a half, rising steadily until the market closed due to expectations of a Fed interest rate cut and a clearer outlook for the US election.

At the close, the S&P 500 index rose 1.07% to 5,554.13 points; the Nasdaq index went from a decline of more than 1% to a final increase of 2.17%, closing at 17,395.53 points; the Dow Jones Industrial Average rose 0.31% to 40,861.71 points.

(The Nasdaq takes off in a 'V' shape, source: TradingView)

Of course, behind all this are layers of various news, collectively driving such a volatile night.

Leading the way is the aftermath of the US presidential candidate debate. With widespread consensus that Harris performed better than expected, the photovoltaic sector emerged as the biggest winner. At Wednesday's close, First Solar rose 15.19%, leading the S&P 500 components. JinkoSolar rose 4.6%, and Daqo New Energy rose 5.76%.

There is also the lithium mining sector. Stimulated by the news that Contemporary Amperex Technology is considering adjusting its production capacity, Albemarle rose 13.58%, ranking second on the S&P 500 components. SQM, another lithium mining company well-known to Chinese investors, also saw a growth of 10.01%. OTC-traded Pilbara Minerals rose 19.09%.

Nvidia (+8.15%) and Super Micro Computer (+7.92%) also made it into the top five gainers of the S&P 500 components. On the news front, Nvidia CEO Jensen Huang boasted at the Goldman Sachs Technology Conference that due to the high demand for Blackwell chips, everyone wants them, which has put some strain on customer relationships. Coupled with positive news from Saudi Arabia, the market value of AI chip industry leader rose by more than $210 billion on Wednesday alone.

(Nvidia daily chart, source: TradingView)

In addition, there is assistance from Moscow. As Russian President Putin said on Wednesday, he hopes that government ministers will consider the possibility of restricting the export of certain strategic raw materials, such as uranium, titanium, or nickel. US uranium raw material producers collectively rose, Cameco rose 6.05%, Denison Mines rose 6.71%, Energy Fuels rose 8.41%, and Uranium Energy rose 12.36%. In addition to raw material stocks, the stock of small nuclear reactor startup Nuscale Power also rose by nearly 6%.

Of course, the "loser group" on Wednesday was full of Trump concept stocks. Trump Media Technology Group fell 10.47%, hitting a new low since its listing through shell acquisition. Private prison concept stocks (Trump emphasized cracking down on illegal immigrants) GEO fell 6.83%, and American Punishment Group fell 2.66%. Bitcoin experienced a huge shock during the day, once fell below the $0.056 million mark, but has now recovered most of its decline. Bank stocks related to his promise to relax financial regulation, especially regional banks, also underperformed the market on Wednesday.

As for the situation where the CPI data has basically locked in a 25 basis-point rate cut by the Fed next week. Krishna Guha, head of international policy/central bank policy at Evercore, said that although he still believes that a 50 basis-point rate cut would be the right choice, Powell is now having a hard time pushing for such a move. Guha also believes that even if the Fed does not cut rates by 50 basis points next week, it may make a rate cut of that magnitude in November.

Hot stocks rose and fell.

On Wednesday, tech giants soared. Apple rose 1.16%, Microsoft rose 2.13%, Amazon rose 2.77%, META rose 1.39%, Google-A rose 1.68%, Tesla rose 0.87%, Nvidia rose 8.15%, and Intel rose 3.48%.

Chinese concept stocks also showed a positive and sunny state, with the Nasdaq China Golden Dragon Index rising by 1.02%. Alibaba rose 1.21%, Baidu rose 2.32%, PDD Holdings rose 2.39%, JD.com rose 2.23%, Netease rose 2.29%, NIO Inc. rose 2.19%, Li Auto Inc. fell 0.1%, and XPeng rose 4.46%.

Other news

NVIDIA CEO: Blackwell's demand is too strong, supply cannot meet demand and customer relationships have become tense.

Jensen Huang, CEO of NVIDIA, said on Wednesday that limited supply of popular chip products has frustrated some customers and strained relationships. Speaking at the Goldman Sachs Technology Conference in San Francisco, he told the audience, "Demand is too strong, everyone wants to be the first to get it, everyone wants to order the most, our customers are quite excited, it's understandable, it's indeed tense, and we are working our best." Huang told the audience that the demand for the latest generation Blackwell chip is strong. NVIDIA has outsourced the physical production of the hardware and the suppliers are working hard to catch up on schedule.

OpenAI is reportedly in talks to raise $6.5 billion from investors at a company valuation of $150 billion. The new valuation, which does not include the funds being raised, is significantly higher than the $86 billion valuation the company sought earlier this year in its proposed acquisition. This solidifies its position as one of the most valuable startups in the world. One insider said that OpenAI is also in talks with banks to borrow $5 billion in revolving loans.

Competition discloses details of weight-loss drug research, causing shares of Novo Nordisk and Eli Lilly to rise.

Disclosure of competitive research details on weight loss drugs triggers rise in Novo-Nordisk and Eli Lilly and Co.

Due to Roche's disclosure on Wednesday, the Phase I trial results of the oral weight loss drug CT-996, which was announced in July, were only obtained from six patients. The uncertainty of the experimental conclusions has led to a 4.20% increase in Novo Nordisk's stock price and a 2.18% increase in Eli Lilly's stock price. Roche also explained that the Phase I trial was a process called titration, aimed at detecting any unexpected side effects early on, and larger clinical trials will be conducted later.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment